Elisa Agostinetto· @ElisaAgostinett · X·· 2 天前评分70
正文 · 原文
At #ESMO26 Rapid oral abstracts session on advanced #breastcancer
@drsarahsam presents BRIDGET 🧠
Adding tucatinib to Trastuzumab/Pertuzumab in HER2+ mBC with isolated intracranial progression ⬆️ brain disease control after local tx
Rare extracranial PDs (n=2)
@OncoAlert
37 浏览 · 5 赞 · 3 转发 · 0 回复
会议摘要
1766RO按 Rapid oral 1: Breast cancer, advanced stage 对上
Health-related quality of life from HER2CLIMB-05: A phase 3 study of tucatinib versus placebo in combination with trastuzumab and pertuzumab as 1L maintenance therapy for HER2+ mBC
https://esmocongress.esmo.org来源：Elisa Agostinetto · x.com